MED1 (Mediator Subunit1) was identified as a key transcriptional coactivator for ERα during both normal mammary gland development and breast tumorigenesis. MED1 takes a key role for the crosstalk between HER2 and ERα pathway. MED1 regulates ERα-mediated transcription and leads to resistance of breast cancer cells to anti-estrogen therapies.